đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This research study is the first of its kind and will allow health care pro...
Status
Completed
Location
UK HeathCare Sports Medicine
Start Date
2013-03
Trial ID
NCT01692756
Treatments Being Tested
The purpose of this study is to determine whether TAC-101 as a second line ...
Status
Terminated
Location
I.R.C.C.S. San Matteo University Hospital, Golgi
Start Date
2008-08-01
Trial ID
NCT00687596
To demonstrate the superiority of the clinical efficacy of 12 weeks' treatm...
Status
Terminated
Location
Sanofi-Aventis
Start Date
2006-04
Trial ID
NCT00344942
Treatments Being Tested
This study was to compare CFZ533 to tacrolimus (TAC) in prevention of organ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-11-28
Trial ID
NCT03663335
This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded,...
Status
Recruiting
Location
University of California, San Diego: Dermatology Clinical Trials Unit
Start Date
2025-05-22
Trial ID
NCT06504160
Optimized treatment algorithm in early rheumatoid arthritis: Methotrexate ...
Status
Completed
Location
Aarhus University Hospital
Start Date
2007-09
Trial ID
NCT00660647
Treatments Being Tested
This study aims to determine the frequency of response to treatment with 3 ...
Status
Terminated
Location
University of Minnesota
Start Date
2011-09
Trial ID
NCT01898806
The purpose of this study is to compare the efficacy of intra-articular ste...
Status
Completed
Location
Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine
Start Date
2010-06
Trial ID
NCT01144533
The purpose of this study was to demonstrate that canakinumab given upon ac...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2010-03
Trial ID
NCT01080131
This study assessed the safety and efficacy of canakinumab pre-filled syrin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05
Trial ID
NCT01356602
Treatments Being Tested